N. Kaul, L. King, S. Chen, P. Kwan and TJ. O'Brien (2026). Ketogenic diet therapy for epilepsy in Australia: insights from the Pharmaceutical Benefits Scheme. Internal medicine journal, 56(6), 1078-1080. https://doi.org/10.1111/imj.70445

PubMed 42054353

[Abstract]
Ketogenic diet therapy is an effective non-pharmacological treatment for drug-resistant epilepsy. Since the first item was listed on the Pharmaceutical Benefits Scheme (PBS) in 2009, we report a 21.6-fold increase in annual PBS expenditure on items related to ketogenic diet therapy. This may reflect an increasing utilisation of ketogenic diet therapy for epilepsy nationally.